Hmmm... USA had 300,000 new infections the other day, that's almost 0.1% of their population.

This link has a break down of the vaccination numbers and the reactions.
yourlocalepidemiologist.com/quick-update/?fbclid=IwAR0jCkyyIRDnI0xZ_QqhgZc5iXzpJdlASQIThXLgp50iCJftCBq7DsWnhk0

D3 said..
It's a vaccine (yes I know there are several that are likely to be available here in Australia this year) that has been proven (in a double blind randomised trial no less) to be extremely effective at preventing infection, or at the very least, significantly reducing the affects/seriousness of being infected with this potentially fatal disease.

People might claim that it's development was rushed, but considering that many labs and companies had already been working on Corona virus vaccines and the near unlimited amounts of cash and resources that were thrown into the RnD this year, it actually seems entirely reasonable to develop a vaccine ready for release less than 10 months after the virus genome was sequenced.

Sure, but a (relatively) small-scale trial over a short time period may not pick up small risks that have an impact on a large population, and an expedited schedule for development and delivery may result in manufacturing/production errors that erode public trust in vaccines.

Eg, 1974 swine flu vaccinations which were rolled out in 7 months and then terminated due to an association with increased risk of Gullain-Barre syndrome; 1955-1963 polio rollout which was contaminated with simian virus (as the virus was grown on monkey tissues and the scientific assumption was that formaldehyde would kill it); or the first polio rollout where one of the labs infected 200,000 kids with live polio rather than the attenuated virus and 40,000 contracted it.

So agree a lot of work has been done, and a lot of resources have gone into it, but there is no substitute for scale and time for verifying efficacy or identifying impacts that may not be visible on a small population. The vaccines we have today are extraordinarily safe because of decades of data and refinement, and there is a risk when a response is undertaken in a compressed timeframe that you introduce a new risk, and also discourage vaccination in general, which would be a worse outcome in the long run.

psychomub said..
www.smh.com.au/national/scientists-call-for-pause-on-astrazeneca-vaccine-rollout-20210112-p56tjt.html

Oh well. It seems the 95% claims were BS after all.

If its only 62% effective, then maybe more people need to get it to get this thing sorted out.

Mr Milk said..
I wonder what happens if you just take a 3rd dose...

Three doses won't work.

If 2 doses provide 62% then a 3rd dose will only get you to 91.5%. Pretty simples maths really.

And 91.5% isn't enough.

Bill's chips crash unless they are running at 100%. At 91.5% they will have to be repeatedly turned off and re-booted. Each time they will lose half the data, even with the backup recovery files. And if they are down for 8.5% of the time this may create issues allowing your mind to go partial or even total recall.

At 91.5% Greta may be able to get to the cellar and active the oxygen generator. And they can't have that.

The first nurses in the UK to get the vaccine are doing great, look for yourselves

C19: IVM V.D HCQ V.C Zn PVP-I REGN LY RMDShare Tweet MetaDownload ImageShare Tweet Early?85%49 ivermectin studies
18 peer reviewed
Early treatment and prophylaxis is effective100% of studies report positive effects. 85% improvement from meta analysis, p50 or comorbidities, showing 2.2% hospitalization and 0.3% death, which authors note is considerably lower than reported in other studies in their region. At least two of z..12/27MetaHill, A., Preprint (Preprint) (meta analysis)meta-analysisMeta-analysis of clinical trials of ivermectin to treat COVID-19 infectionWHO-funded meta analysis showing ivermectin treatment mortality relative risk RR 0.17 [0.08-0.35] for RCTs and RR 0.28 [0.13-0.62] for RCTs and observational studies, and confirming a dose-response effect.12/24In VitroJeffreys et al., bioRxiv, doi:10.1101/2020.12.23.424232 (Preprint) (In Vitro)in vitroRemdesivir-Ivermectin combination displays synergistic interaction with improved in vitro antiviral activity against SARS-CoV-2In Vitro study showing enhanced antiviral activity of ivermectin and remdesivir in combination.12/20PrEPPEPVallejos et al. (News)cases, ?78.6%, p 0.05. Negative PCR results were not signific..8/28PrEPPEPShouman et al., NCT04422561 (Preprint)symp. case, ?91.3%, p<0.001Use of Ivermectin as a Prophylactic Option in Asymptomatic Family Close Contacts with Patients of COVID-19PEP trial for asymptomatic close contacts of COVID-19 patients, 203 ivermectin patients and 101 control patients. 7.4% of contacts developed COVID-19 in the ivermectin group vs. 58.4% in the control group, adjusted odds ratio OR 0.087, p ..8/15EarlyEspitia-Hernandez et al., Biomedical Research, 31:5 (Peer Reviewed)viral+, ?97.2%, p<0.0001Effects of Ivermectin-azithromycin-cholecalciferol combined therapy on COVID-19 infected patients: A proof of concept studySmall study with 28 patients treated with ivermectin + AZ + cholecalciferol and 7 control patients. All treated patients were PCR- at day 10 while all control patients remained PCR+. The mean duration of symptoms was 3 days in the treatm..8/14LateBhattacharya et al., Int. J. Scientific Research, doi:10.36106/ijsr/7232245 (Peer Reviewed)Observational Study on Clinical Features, Treatment and Outcome of COVID 19 in a tertiary care Centre in India- a retrospective case seriesRetrospective 148 hospitalized patients showing triple therapy with ivermectin + atorvastatin + N-acetylcysteine resulted in a 1.35% case fatality rate which was well below the national average.7/31LateChang et al., ResearchGate (Preprint)Post-acute or prolonged COVID-19: ivermectin treatment for patients with persistent symptoms or post-acute symptomsReport on 33 patients with persistent or post-acute symptoms treated with ivermectin, showing a high rate of clinical improvement.7/31TheoryChang et al., ResearchGate, doi:10.13140/RG.2.2.34561.48483/2 (Preprint) (Theory)theoryCOVID-19: Post-exposure prophylaxis with ivermectin in contacts. At Homes, Places of Work, Nursing Homes, Prisons, and OthersProposed PEP protocol based on ivermectin.7/31LateAlam et al., Journal of Bangladesh College of Physicians and Surgeons, doi:10.3329/jbcps.v38i0.47512 (Peer Reviewed)A Case Series of 100 COVID-19 Positive Patients Treated with Combination of Ivermectin and DoxycyclineCase study of 100 patients treated with ivermectin and doxycycline, with no ICU admission, deaths, or serious side effects reported.7/31LateRahman et al., J. Bangladesh Coll. Phys. Surg. 38, 5-9, doi:10.3329/jbcps.v38i0 (Peer Reviewed)Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 PatientsComparison of 200 patients treated with ivermectin + doxycycline and 200 treated with HCQ + AZ. The HCQ + AZ group had more severe cases at baseline. Viral clearance was faster with ivermectin + doxycycline. Ivermectin dose is given all o..7/14EarlyChowdhury et al., Research Square, doi:10.21203/rs.3.rs-38896/v1 (Preprint)A Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patientsSmall 116 patient RCT comparing Ivermectin-Doxycycline and HCQ+AZ, not showing a significant difference in time to PCR negative or symptom resolution. Time to symptomatic recovery was 5.93 days for Ivermectin-Doxycycline vs. 6.99 days for..7/8LateGorial et al., medRxiv, doi:10.1101/2020.07.07.20145979 (Preprint)death, ?71.0%, p=1.00Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (Pilot Trial)Small trial of hospitalized patients with 16 of 87 patients being treated with ivermectin showing a significantly lower mean hospital stay with ivermectin: 7.62 vs. 13.22 days, p=0.00005. 0 of 16 ivermectin patients died vs. 2 of 71 cont..6/30In VitroCaly et al., Antiviral Research, doi:10.1016/j.antiviral.2020.104787 (Peer Reviewed) (In Vitro)in vitroThe FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitroIn Vitro study showing that ivermectin is an inhibitor of SARS-CoV-2, with a single addition to Vero-hSLAM cells 2h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48h.6/19TheoryLehrer et al., In Vivo, 34:5, 3023-3026, doi:10.21873/invivo.12134 (Theory)theoryIvermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2In silico analysis showing ivermectin docking which may interfere with the attachment of the spike to the human cell membrane.6/12ReviewHeidary et al., The Journal of Antibiotics, 73, 593-602, doi:10.1038/s41429-020-0336-z (Review) (Peer Reviewed)reviewIvermectin: a systematic review from antiviral effects to COVID-19 complementary regimenReview of the antimicrobial, antiviral, and anti-cancer properties of ivermectin. Antiviral effects have been reported for Zika, dengue, yellow fever, West Nile, Hendra, Newcastle, Venezuelan equine encephalitis, chikungunya, Semliki For..5/2EarlyChang, G., Research Gate, doi:10.13140/RG.2.2.34689.48482/7 (Preprint)Inclusi?n de la ivermectina en la primera l?nea de acci?n terap?utica para COVID-19Peru observational case study of 7 patients treated with ivermectin, showing improvement and resolution of fever within 48 hours, and 100% recovery.

The NSW premier just said this morning at one of their press conferences that she would like to see an app that you could show prior to entering a business, eg restaurant etc, that you had been vaccinated.
Now my first thought was that any business that restricts access is on a sure road to bankruptcy, but maybe people who are vaccinated will seek out these businesses.
Could become a bit like smokers, you lot sit out there.

Carantoc said..
Thing I've been wondering about is whether tin-foil facemasks would block the 5G signals from the chips in the vaccine.

Could be a way to get all the benefits but none of the downsides ?


A double layer tin-foil full face mask with a crystal in it would surely work.

That's a false hood they are using newer technology 7g which is foilproof

Carantoc said..
Thing I've been wondering about is whether tin-foil facemasks would block the 5G signals from the chips in the vaccine.

Could be a way to get all the benefits but none of the downsides ?


A double layer tin-foil full face mask with a crystal in it would surely work.

The tinfoil just makes a better antenna so we can read your thoughts and control you.

30 adverse reactions in Norway from 30,000 vaccinations, 13 deaths... 3/10,000, isn't that the same as the virus itself?

Buster fin said..

Kamikuza said..
30 adverse reactions in Norway from 30,000 vaccinations, 13 deaths... 3/10,000, isn't that the same as the virus itself?

Ummm 3/1000. Sounds 10x worse than the virus.

...in 'frail, elderly' people. Exactly the reason young and healthy people need to get it to protect your grandparents.

15% chance of dying in this age bracket if you get covid so still better than the virus

But the disease has been kept out of NZ by strong border control and a hard lockdown. That can't go on forever.

Arguing against the vaccine because a small number of people have a bad reaction makes about as much sense as saying that bushfire fighters shouldn't do backburns because a few trees get burned.

www.hpj.com/ag_news/could-ivermectin-be-an-answer-to-both-parasites-and-pandemics/article_0b578c96-5529-11eb-b6bc-f78e273cbf37.html?fbclid=IwAR3TVRvEQ1vLPrYrbbfdUNKjnV-ebqYGVPLseYheWCu9dCC8C1YyGhxPGjQ

not exactly revising it to a resounding positive:

Because of these limitations, the Panel cannot draw definitive conclusions about the clinical efficacy or safety of ivermectin for the treatment of COVID-19. Results from adequately powered, well-designed, and well-conducted clinical trials are needed to provide more specific, evidence-based guidance on the role of ivermectin for the treatment of COVID-19.

www.ibtimes.com/miracle-drug-ivermectin-unproven-against-covid-scientists-warn-3123213

www.reuters.com/article/uk-factcheck-vaccines-video/fact-check-younger-people-may-be-affected-by-covid-19-coronavirus-cases-will-not-disappear-within-six-weeks-ivermectin-is-not-a-proven-treatment-idUSKBN29J2K1

nypost.com/2021/01/15/23-die-in-norway-after-receiving-pfizer-covid-19-vaccine/

23 now dead not that it will make an ounce of difference to pro vaxxers when their ego is at stake.